Shanghai - Delayed Quote • CNY Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) Follow Compare 20.05 +0.35 +(1.78%) At close: January 27 at 3:00:03 PM GMT+8 All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations CABIO Deepens Commitment to Global Markets, Aiming to Serve International Clients and Pursue Long-Term International Partnerships CABIO, a high-tech enterprise underpinned by biotechnology and listed on the Science and Technology Innovation Board (stock code: 688089), unveiled its innovative product, NeoHMOs®, at the Food Ingredients Europe event held in Frankfurt, Germany. Recently, CABIO's Human Nutrition Business Unit has made frequent appearances in international exhibitions, participating in events such as SupplySide West in Las Vegas, USA, and Food Ingredients Europe. These participations have facilitated discussions Performance Overview Trailing total returns as of 1/27/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index Return 688089.SS SSE Composite Index YTD +3.72% -4.60% 1-Year +35.17% +11.70% 3-Year -46.12% -5.93%